HU-308 (C005B-257382)

Catalog No.: C005B-257382
Manufacturer No.: H-158-1ML
Manufacturer Name: Cerilliant
Quantity: 1
Unit of Measure: EA

General description HU-308 is a synthetic cannabinoid that acts as a potent, highly selective agonist for the CB2 receptor. HU-308 is evaluated to be effective against the cytokine release syndrome (CRS), that is seen in many diseases and

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

General description

HU-308 is a synthetic cannabinoid that acts as a potent, highly selective agonist for the CB2 receptor. HU-308 is evaluated to be effective against the cytokine release syndrome (CRS), that is seen in many diseases and conditions, including COVID-19. A certified Snap-N-Spike^® solution suitable for use as starting material in calibrators and controls for LC/MS or GC/MS testing methods in clinical toxicology, urine drug testing, forensic analysis and pharmaceutical research applications.

Legal Information

CERILLIANT is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Cerilliant Corporation

UPC:: 41113401
Condition:: New
HazmatClass:: No
MPN:: H-158-1ML
CAS:: 256934-39-1

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."